< 1 minute read
Dec. 10, 2021
Compound 44: a Bicyclic Macrocyclic Peptide PCSK9 Inhibitor
compound 44
bioavailable bicyclic macrocycle PCSK9 inh. %F cyno = 2.9, MW 1612, preclinical from mRNA display screen and SBDD Journal of Medicinal Chemistry Merck & Co.
Loading...
